Latest News of AYTU
Q4 2024 Aytu Biopharma Inc Earnings Call
By Yahoo! Finance |
1 month ago
Joshua Disbrow, CEO of Aytu Biopharma, discusses the fiscal 2024 Q4 earnings call with positive results. Focus on Rx business growth, pediatric portfolio improvement, and leveraging RxConnect for futu...
Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long
By Yahoo! Finance |
1 month ago
Aytu BioPharma, Inc. is a pharmaceutical company approaching breakeven with potential for profitability in 2025. Analysts predict a 96% growth rate is needed for profitability, noting the company's hi...
It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year
By Yahoo! Finance |
4 months ago
Aytu BioPharma's EPS increased by 71% in three years, but shareholders experienced a 97% loss. Shareholders can address concerns at the upcoming AGM on June 26, including CEO compensation....